Listeria May Pose Serious Threat Early in Pregnancy
|
By LabMedica International staff writers Posted on 01 Mar 2017 |

Image: In pregnant women, Listeria monocytogenes can cause miscarriage, as well as early pregnancy, stillbirth, and premature labor (Photo courtesy of the CDC).
From their study of how Listeria affects the fetus, researchers suggest that infection with Listeria monocytogenes likely poses a greater risk of miscarriage in the early stages of pregnancy than has been appreciated.
"Listeria has been associated with adverse outcomes in pregnancy, but particularly at the end of pregnancy," said senior author Ted Golos, of University of Wisconsin-Madison, "What wasn't known with much clarity before this study is that it appears it's a severe risk factor in early pregnancy."
"The problem with this organism is not a huge number of cases. It's that when it is identified, it's associated with severe outcomes," said co-author Charles Czuprynski, professor at UW-Madison. Pregnant women are warned to avoid many of the foods that can harbor Listeria, and severe outcomes have resulted in a zero-tolerance regulatory policy for Listeria in ready-to-eat foods.
But Listeria infection in pregnancy may go unnoticed; the few recognizable symptoms are nearly indistinguishable from the discomfort most newly pregnant women feel. Yet "it has a profound impact on the fetus," said Prof. Golos, "That's familiar now because we've been talking about the same difference in Zika virus."
For the study, Sophia Kathariou, professor at North Carolina State University, provided a strain of Listeria that caused miscarriage, stillbirth, and premature delivery in at least 11 pregnant women in 2000. Four pregnant rhesus macaques at the Wisconsin National Primate Research Center were fed doses of the Listeria comparable to what one might encounter in contaminated food. Lead author Bryce Wolfe, a UW-Madison graduate student, monitored the speed and progression of Listeria's spread.
"What's particularly striking about the work Bryce did is the detailed information we now have about the organism," said Prof. Czuprynski, "she tracked it being shed in feces and showing up in the bloodstream. They did ultrasound analysis of the fetus, and could then show events in terms of where the organism was preceding fetal demise."
None of the monkeys showed obvious signs of infection before their pregnancies came to abrupt ends. But in tissue samples taken after each monkey experienced intrauterine fetal death, Wolfe found Listeria had invaded the placenta. "In that region there's a rich population of specialized immune cells, and it is exquisitely regulated," said Wolfe, "When you introduce a pathogen into the midst of this, it's not very surprising that it's going to cause some sort of adverse outcome disrupting this balance."
The researchers suggest the inflammation caused by the maternal immune response affects the placenta, preventing it from protecting the fetus. "It should be a barrier," said Prof. Golos, "But we're hypothesizing that the maternal immune system's attempt to clear the bacteria actually results in collateral damage to the placenta that then allows the bacteria to invade the fetus."
The results suggest Listeria (and perhaps other pathogens) may be the culprit in some miscarriages that usually go without diagnosed cause, but the bacteria's stealth and speed may still make it hard to control. "There are effective antibiotics available. It is treatable," said Wolfe, but "the fetus may be infected by the time anyone realizes the mother was infected."
The researchers plan to further investigate progression of infection and the maternal immune response to intracellular pathogens in pregnancy, in hope that such basic knowledge would help battle this and similar dangers, such as Zika virus.
The study, by Wolfe B et al, was published February 21, 2017, in the journal mBio.
"Listeria has been associated with adverse outcomes in pregnancy, but particularly at the end of pregnancy," said senior author Ted Golos, of University of Wisconsin-Madison, "What wasn't known with much clarity before this study is that it appears it's a severe risk factor in early pregnancy."
"The problem with this organism is not a huge number of cases. It's that when it is identified, it's associated with severe outcomes," said co-author Charles Czuprynski, professor at UW-Madison. Pregnant women are warned to avoid many of the foods that can harbor Listeria, and severe outcomes have resulted in a zero-tolerance regulatory policy for Listeria in ready-to-eat foods.
But Listeria infection in pregnancy may go unnoticed; the few recognizable symptoms are nearly indistinguishable from the discomfort most newly pregnant women feel. Yet "it has a profound impact on the fetus," said Prof. Golos, "That's familiar now because we've been talking about the same difference in Zika virus."
For the study, Sophia Kathariou, professor at North Carolina State University, provided a strain of Listeria that caused miscarriage, stillbirth, and premature delivery in at least 11 pregnant women in 2000. Four pregnant rhesus macaques at the Wisconsin National Primate Research Center were fed doses of the Listeria comparable to what one might encounter in contaminated food. Lead author Bryce Wolfe, a UW-Madison graduate student, monitored the speed and progression of Listeria's spread.
"What's particularly striking about the work Bryce did is the detailed information we now have about the organism," said Prof. Czuprynski, "she tracked it being shed in feces and showing up in the bloodstream. They did ultrasound analysis of the fetus, and could then show events in terms of where the organism was preceding fetal demise."
None of the monkeys showed obvious signs of infection before their pregnancies came to abrupt ends. But in tissue samples taken after each monkey experienced intrauterine fetal death, Wolfe found Listeria had invaded the placenta. "In that region there's a rich population of specialized immune cells, and it is exquisitely regulated," said Wolfe, "When you introduce a pathogen into the midst of this, it's not very surprising that it's going to cause some sort of adverse outcome disrupting this balance."
The researchers suggest the inflammation caused by the maternal immune response affects the placenta, preventing it from protecting the fetus. "It should be a barrier," said Prof. Golos, "But we're hypothesizing that the maternal immune system's attempt to clear the bacteria actually results in collateral damage to the placenta that then allows the bacteria to invade the fetus."
The results suggest Listeria (and perhaps other pathogens) may be the culprit in some miscarriages that usually go without diagnosed cause, but the bacteria's stealth and speed may still make it hard to control. "There are effective antibiotics available. It is treatable," said Wolfe, but "the fetus may be infected by the time anyone realizes the mother was infected."
The researchers plan to further investigate progression of infection and the maternal immune response to intracellular pathogens in pregnancy, in hope that such basic knowledge would help battle this and similar dangers, such as Zika virus.
The study, by Wolfe B et al, was published February 21, 2017, in the journal mBio.
Latest Microbiology News
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
- Blood-Based Diagnostic Method Could Identify Pediatric LRTIs
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







